← Leaderboards
Daniel Gil
Siege Pharmaceuticals, Inc.
$1,008,833
Attributed
$1,008,833
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,008,833 · 1
By mechanism
R44$1,008,833 · 1
Top collaborators
No co-investigators on record.
Most similar at Siege Pharmaceuticals, Inc.
Same institution · by research overlap
- Alison Nicole McCracken$1,287,564
Others in their field
Other Emerging Leaders on “Amino Acids”
- Alan James Bridge · European Molecular Biology Laboratory$8,787,716
- Ian R Lanza · Mayo Clinic Rochester$5,625,920
- Chitra Upadhyay · Icahn School Of Medicine At Mount Sinai$4,972,038
- Rui Kong · Emory University$4,675,382
- Ahmed Abdelfattah · Brown University$4,550,209
- Alon Herschhorn · University Of Minnesota$4,482,305
Research focus
Amino AcidsAndrogen ReceptorAnticancer ActivityAntigensBenchmarkingBone MarrowCancer CellCancer PatientCancer TherapyCanis FamiliarisCardiovascular SystemCause Of DeathCell NucleusCellsCharacteristicsChemotherapyClinical ApplicationClinical ResearchClinical Trials DesignCombined Modality TherapyCross PresentationCytotoxic ChemotherapyDendritic CellsAddiction